Target intelligence / Profile preview

Primary and Secondary Cytotoxicity

Molecular classification
Other (not a molecule, receptor, or protein)
01

Overview

Primary and secondary cytotoxicity does not refer to any specific molecule, receptor, enzyme, transporter, or other canonical therapeutic target. Instead, it describes the general property of being toxic to cells—i.e., causing cell damage or death through processes such as necrosis or apoptosis. Cytotoxic effects can be caused by chemicals, drugs (such as chemotherapeutics), toxins, immune cells like cytotoxic T lymphocytes and natural killer cells, radiation particles, etc. In immunology and oncology research contexts: - Primary cytotoxicity may refer to direct killing of target cells by agents such as immune effector cells. - Secondary cytotoxicity could refer to subsequent rounds of cell death following initial injury/apoptosis/necrosis. However, these are descriptive terms for biological outcomes rather than names for discrete molecular targets. Therefore this entry should be flagged as incorrect if used in place of an actual druggable protein/receptor/enzyme.

02

Biological functions

Cell deathImmune responseApoptosisNecrosisCell proliferation inhibition
03

Disease associations

Cancer (as a process relevant to chemotherapy and immune surveillance)Infection (immune-mediated cytotoxicity against infected cells)Other (general cell damage in toxicology and pharmacology contexts)

Beyond the preview

Go deeper on Primary and Secondary Cytotoxicity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primary and Secondary Cytotoxicity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call